Skip to main content

Artificial Intelligence (AI) and the COVID-19 Vax

Youth and young adults have questions about the COVID-19 vaccine, and they are commonly fluent in technology use. These worlds are colliding with Vira, the Vax Chatbot, powered by artificial intelligence and designed to answer simple questions on the COVID-19 vaccine. The automated chat also has an option to provide feedback to the developers for improvements. 

Featuring…

Vira, the Vax Chatbot

Artificial Intelligence is a rising, popular technology like Google's Assistant, Microsoft's Cortana, or Amazon's Alexa. Vira is an artificial intelligence chatbot powered by IBM that connects to a database of COVID-19 vaccines information and learning to answer the questions efficiently. Vira was "developed by the International Vaccine Access Center at the Johns Hopkins Bloomberg School of Public Health with experts from the Bloomberg School's Department of International Health and Johns Hopkins Whiting School of Engineering (Covington Michelle, personal communication, Oct 04, 2021)."

Are you excited to learn more about Vira? Let us know in the comments below! For youth and young adults, ages 13-26, join us on the SPAN Youth Chat on Wednesdays from 3:30 - 4:00 PM. 

Author,

Jeremy Hayer

Resources...

Vira, the Vax Chatbot: https://youtu.be/t6z2tKe47kQ

Link to SPAN’s website: www.spanadvocacy.org 

Link to SPAN’s Youth in the Know Resource Page: Youth in the Know

We’re here for you! Call SPAN if you need assistance: 1-800-654-7726


Comments

Popular posts from this blog

Building Your Circle: Helping Youth Discover Their Support Networks

Having a personal support network is important for dealing with challenges and working toward your goals. Whether you are in school, starting your career, or living with a disability, it helps to have people you can count on. These networks do not appear on their own—you build them by talking with others, staying connected, and building trust. Learning what a support network is, and why it matters, is the first step.  

Rutgers RWJMS Seeks Children and Young Adult Participants in Long COVID Study

RECOVER is a research project that aims to learn about the long-term health effects of COVID. Rutgers Robert Wood Johnson Medical School (RWJMS) has been awarded a $30 million+ grant from the NIH to help lead a study on the long-term and delayed impacts of COVID-19 in children and young adults. This study is designed to answer these questions: -How many children get Long COVID? -Why do some children get Long COVID and others do not? -What symptoms do children feel when they get Long COVID? -How long do children feel sick when they get Long COVID? -What causes Long COVID to happen in children? -How does having Long COVID affect children's physical and mental health and development as they grow? Eligible subjects include infants, children, adolescents, and young adults through 25 years of age. Infection with COVID is not necessary to participate. The study's first phase includes a home questionnaire and blood and saliva samples provided from the comfort of your h...

Next-Gen Voices: Using A.I. to Strengthen Self-Advocacy, featuring No Hate In The Garden State

The use of A.I (Artificial Intelligence) programs, like ChatGPT and Gemini, has sparked debates and discussions about it’s use in our daily lives. While A.I can be used in negative ways, there are many opportunities for youth and young adults to use it as a tool for self-advocacy and self-improvement.